Skip to content
10-Q

Quarterly Report

American CryoStem Corporation

0001019056-21-000487

← back to feed
Filed
Aug 23, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2021 · Aug 13, 2021 60.58M sh
Current Liabilities Q3 2021 · Jun 30, 2021 $1.19M
Current Liabilities Q3 2021 · Sep 30, 2020 $1.05M
Total Liabilities Q3 2021 · Jun 30, 2021 $2.39M
Total Liabilities Q3 2021 · Sep 30, 2020 $1.9M
Current Assets Q3 2021 · Jun 30, 2021 $907.71K
Current Assets Q3 2021 · Sep 30, 2020 $567.16K
Total Assets Q3 2021 · Jun 30, 2021 $1.78M
Total Assets Q3 2021 · Sep 30, 2020 $1.48M
Capex Q3 2021 · Jun 30, 2020 $3.88K
Operating Cash Flow Q3 2021 · Jun 30, 2020 −$419.8K
Cash And Equivalents Q3 2021 · Jun 30, 2020 $28.58K
Cash And Equivalents Q3 2021 · Sep 30, 2019 $23.8K
Stockholders Equity Q3 2021 · Jun 30, 2020 −$1.13M
Stockholders Equity Q3 2021 · Mar 31, 2020 −$1.48M
Stockholders Equity Q3 2021 · Sep 30, 2019 −$1.24M
Net Income Q3 2021 · Jun 30, 2020 −$230.46K
Net Income Q3 2021 · Jun 30, 2020 −$649.54K
Operating Income Q3 2021 · Jun 30, 2020 $79
Operating Income Q3 2021 · Jun 30, 2020 −$441.99K
Gross Profit Q3 2021 · Jun 30, 2020 $133.93K
Gross Profit Q3 2021 · Jun 30, 2020 $411.69K
Cost Of Revenue Q3 2021 · Jun 30, 2020 $4.51K
Cost Of Revenue Q3 2021 · Jun 30, 2020 $21.22K
Revenue Q3 2021 · Jun 30, 2020 $138.44K
Revenue Q3 2021 · Jun 30, 2020 $432.9K